- Report
- November 2023
- 1800 Pages
Global
From €4926EUR$5,100USD£4,215GBP
- Report
- November 2023
- 88 Pages
Global
From €1932EUR$2,000USD£1,653GBP
- Report
- September 2023
- 75 Pages
Global
From €3187EUR$3,300USD£2,727GBP
- Report
- March 2024
- 193 Pages
Global
From €3259EUR$3,374USD£2,789GBP
€3621EUR$3,749USD£3,099GBP
- Report
- January 2024
- 483 Pages
Global
From €6906EUR$7,150USD£5,909GBP
- Report
- March 2024
- 373 Pages
Global
From €5261EUR$5,638USD£4,350GBP
- Report
- March 2024
- 194 Pages
Global
From €3259EUR$3,374USD£2,789GBP
€3621EUR$3,749USD£3,099GBP
- Report
- February 2024
- 220 Pages
Global
From €1922EUR$1,990USD£1,645GBP
- Report
- April 2024
- 453 Pages
Global
From €5602EUR$5,800USD£4,794GBP
- Report
- November 2023
- 138 Pages
Global
From €2414EUR$2,499USD£2,065GBP
- Report
- April 2024
- 803 Pages
Global
From €5409EUR$5,600USD£4,628GBP
- Report
- February 2024
- 175 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- February 2024
- 125 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- November 2023
- 174 Pages
Global
From €2415EUR$2,500USD£2,066GBP
- Report
- December 2023
- 115 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- March 2024
- 200 Pages
Global
From €4008EUR$4,150USD£3,430GBP
- Report
- November 2023
- 140 Pages
Global
From €4298EUR$4,450USD£3,678GBP
- Report
- August 2023
- 145 Pages
Global
From €3042EUR$3,150USD£2,603GBP
Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more